LEADER 02063nam  2200625 a 450 
001 9910454187703321
005 20200520144314.0
010   $a1-281-30747-5
010   $a9786611307479
010   $a92-4-068233-3
035   $a(CKB)1000000000689245
035   $a(EBL)329014
035   $a(OCoLC)476127796
035   $a(SSID)ssj0000283198
035   $a(PQKBManifestationID)11236302
035   $a(PQKBTitleCode)TC0000283198
035   $a(PQKBWorkID)10337598
035   $a(PQKB)10568031
035   $a(MiAaPQ)EBC329014
035   $a(Au-PeEL)EBL329014
035   $a(CaPaEBR)ebr10214534
035   $a(CaONFJC)MIL130747
035   $a(EXLCZ)991000000000689245
100   $a20081023d2007      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aPromoting safety of medicines for children$b[electronic resource] /$fWorld Health Organization
210   $aGeneva $cWorld Health Organization$d2007
215   $a1 online resource (64 p.)
300   $aDescription based upon print version of record.
311   $a92-4-156343-5 
320   $aIncludes bibliographical references.
327   $aIntroduction -- Current situation -- The essential role of safety monitoring in the life-cycle of a medicine -- Medication errors -- Primary responsibility of stakeholders -- Guidance : measures to be taken -- Measures to be taken by WHO.
606   $aDrugs$xSafety measures
606   $aDrugs$xToxicology
606   $aDrug monitoring
606   $aPediatric pharmacology
608   $aElectronic books.
615  0$aDrugs$xSafety measures.
615  0$aDrugs$xToxicology.
615  0$aDrug monitoring.
615  0$aPediatric pharmacology.
676   $a615.58083
676   $a615.58083615.542
712 02$aWorld Health Organization.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910454187703321
996   $aPromoting safety of medicines for children$92026791
997   $aUNINA